Search

eNews Sign-Up!

Edit Profile  
Sign-up to receive our quarterly e-newsletter full of healthy advice.
*
*
*

Hospital Research & Clinical Trials

  • Contact Us
  • Publications

    PubMed Central (PMC) is the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature.  You can view an abstract of the articles below by clicking on the link PubMed Central.

    Hartsell, W., Scott, C., Watkins-Bruner, D., Scarantino, C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B.,  Petersen, I., Konski, A., Cleeland, C., Janjan, N. and DeSilvio, M.: Randomized Trial of Short- Versus Long- Course Radiotherapy for Palliation of Painful Bone Metastases. J. Natl Cancer Inst (JNCI), 97 (11):798-804,  2005.

    Hartsell, W., Winter, K., Watkins-Bruner, D., Scarantino C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B.,  Petersen, Iand Konski, A.: Breast Cancer Patients Have Better Outcomes than Prostate Cancer Patients for  Palliation of Painful Bone Metastases: Results of RTOG 97-14. Proc Am Soc Clin Oncol (ASCO), Orlando,  FL, J Clin Oncol, [23] (16S) pg. 546s, Abs. #6073, 2005.

    Choy, H., Swann, S., Walter, C., Whipple, G., Demas, W. and Ettinger, D.: A Phase I trial of Gemcitabine, Carboplatin  or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and  Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. Proc Am Soc Clin Oncol  (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 646s, Abs. #7103, 2005.

    Choy, H., Swann, S., Walter, C., Whipple, G., Demas, W. and Ettinger, D.: A Phase I trial of Gemcitabine, Carboplatin  or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and  Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. Proc Amer Soc Thera  Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg S42-S43, Abs. #70, 2005.

    Choy, H., Swann, S., Walter, C., Whipple, G., Demas, W. and Ettinger, D.: A Phase I trial of Gemcitabine, Carboplatin  or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and  Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. International Assoc  Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] (Suppl 2) pg. S270-S271, Abs. #P-578,  2005.

    H.I. Robins, M. Won, W. Seiferheld, C. Schultz, A. Choucair, D. Brachman, W. Demas, M. Mehta; University of Wisconsin, Madison, WI; RTOG, Philadelphia, PA; Medical College of Wisconsin, Milwaukee, WI; LDS Hospital, Salt Lake City, UT; Foundation for Cancer Research and Education, Phoenix, AZ; Summa Health Systems, Akron, OH. A phase II trial of conventional radiation therapy plus high dose tamoxifen  for the treatment of supratentorial glioblastoma multiforme: RTOG protocol BR-0021. (Scheduled for publication in the Journal of the Society of Neuro-Oncology, 2005)

    Choy, H., Swann, S., Curran, W., Whipple, G., Demas, W., and Ettinger, D.:  A Phase I trial of Gemcitabine,  Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative  Gemcitabine and Carboplatin for Inoperable State III Non-Small Cell Lung Cancer: An RTOG Study.   Proceedings of Proc Am Soc Clin Oncol (ASCO), J Clin Oncol 23:646s, 2005.

    Hartsell, W., Winter, K., Watkins-Bruner, D., Scarantino, C., Ivker, R., Roach III, M., Suh, J., Demas, W.,  Movsas, B., Petersen, I. and Konski, A.: Breast Cancer Patients Have Better Outcomes than Prostate  Cancer Patients for Palliation of Painful Bone Metastases: Results of RTOG 97-14.  Proceedings of Proc  Am Soc Clin Oncol (ASCO), J Clin Oncol 23:546s, 2005.

    Garden, A.S., Harris, J., Vokes, E., Forastiere, A., Ridge, J., Jones, C., Horwitz, E., Glisson, B., Nabell, L.,  Cooper, J., Demas, W. and Gore, E.:  Preliminary Results of Radiation Therapy Oncology Group 97-03:  A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell  Carcinomas of the Head and Neck. J Clin Oncol, 22 (14): 2856-2864, 2004.

    Andrews, D., Scott, C., Sperduto, P., Flanders, A., Gaspar, L., Schell, M., Werner-Wasik, M., Demas, W., Ryu,J., Bahary, J., Souhami, L., Rotman, M., Mehta, M., Curran, W.:  Whole Brain Radiation Therapy with or without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases:  Phase III Results of the RTOG 9508 Randomized Trial.  The Lancet, May 22, 2004.

    Robins, H., Won, M., Schultz, C., Choucair, A., Brachman, D., Demas, W. and Mehta, M.: A Phase II Trial of Conventional Radiation Therapy (XRT) Plus High Dose Tamoxifen (TAM) for the Treatment of Supratentorial Glioblastoma Multiforme (GBM): RTOG Protocol BR-0021. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 114, Abs. #1529, 2004.

    Robins, H., Won, M., Sieferheld, W., Schultz, C., Choucair, A., Brachman, D., Demas, W. and Mehta, M.:  A Phase II Trial of Conventional Radiation therapy (XRT) Plus High Dose Tamoxifen (TAM) for the Treatment of Supratentorial Glioblastoma Multiforme (GBM): RTOG Protocol BR-0021.  Proc from Soc for Neuro-Oncology (SNO), Toronto, Canada, Neuro-Oncol. [6] (4) pg. 363, Abs. #RT-19, 2004. 

    Choy, H., Swann, S., Sandler, A., Whipple, G., Demas, W., and Ettinger, D.:  A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer:  An RTOG Study.  International Assoc Study of Lung Cancer (IASLC), Vancouver, British Columbia, Lung Cancer Meeting Booklet, pg. 62, Abs. #P-171, 2003.

    Hartsell, W., Scott, C., Watkins Bruner, D., Scarantinio, C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B., Petersen, I. and Konski, A.:  Phase III Randomized Trial of 8 Gy in 1 Fraction vs. 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases:  Preliminary Results of RTOG 9714.  Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57} (2) pg. S124, Abs. #1, 2003.

    Bradley, J., Scott, C., Paris, K., Demas, W., Machtay, M., Komaki, R., Movasa, B., Rubin, P. and Sause, W.:  A Phase III Comparison of Radiation Therapy With or Without Recombinant b-Interferon for Poor Risk Patients with Locally Advanced Non-Small Cell Lung Cancer.  (RTOG 93-04) Int J Radiat Onco Biol Phys., 52(5):1173-1179, 2002.

    Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.: RTOG 9508: A Prospective Randomized Trial of Stereotactic Radiosurgery and Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone in Patients with 1-3 Brain Metastases Patients; Results and Salvage Therapy Analyses. Proc from Soc for Neuro-Oncology (SNO), San Diego, CA, Soc for Neuro-Onc Meeting Program, pg. 359-360, Abs. #188, 2002.

    Sperduto, P., Scott, C., Andrews, D., Schell, M., Flanders, A., Werner-Wasik, M., Demas, W., Ryu, J., Gaspar, L., Bahary, J.-P., Souhami, L., Rotman, M. and Curran, W.:  Stereotactic Radiosurgery With Whole Brain Radiation Therapy Improves Survival in Brain Metastases Patients:  Report of Radiation Therapy Oncology Group Phase III Study 95-08.   Proc Am Soc Ther Rad Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, pg.  3, Abs #5, P.2002.

    Calvin DP, Hammond MEH, Pajak TF, Trotti A, Meredith R, Rotman M, Jones C, Demas W, Byhardt R, Ang KK, and Fu KK.:  Microvessel Density (MVD) > 60 Does Not Predict for Outcome in Advanced Head and Neck Squamous Cell Carcinoma:  Results of a Prospective Study from the RTOG 90-03 Trial.  Int. J. RadiationOncology Biol. Phys., Vol. 51, No. 3, p.41, 2001.

    Owen, J., Grigsby, P., Caldwell, T., Konski, A., Johnson, D., Demas, W., Movsas, B., Jones, C. V. and Wasserman, T.: Can Costs Be Measured And Predicted By Modeling Within A Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of Radiation Therapy Oncology Group (RTOG) Studies 90-03 and 91-04. Int J Radiat Oncol Biol Phys, 49(3):633-639, 2001.

    Herskovic, A., Scott, C., Demas, W., Gaspar, L. and Trotti, A.:  Accelerated Hyperfractionation for Bronchogenic Cancer ¡V RTOG 92-05.  Am J Clin Oncol, 23(2):207-212, 2000.

    Murray K, Scott C, Zachariah B, Michalski J, Demas W, Vora N, Whitton A, Movasas B:  Importance of the Mini-Mental Status Examination in the Treatment of Patients With Brain Metastases: A Report From the Radiation Therapy Oncology Group Protocol 91-04, Int. J. RadiationOncology Biol. Phys., Vol. 48, No. 1, pp 59-64, 2000.

    Sperduto, P., Scott, C., Andrews, D., Schell, M., Werner-Wasik, M., Demas, W., Ryu, J., Fontenesi, J., Rotman, M. and Curran, W.: Preliminary Report of RTOG 95-08: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 113, Abs. #6, 2000.

    Owen JB, Grigsby PW, Caldwell TM, Konski A, Johnson D, Demas W, Movsas B, Jones CV, Wasserman T.:  Can Costs Be Measured and Predicted by Modelling Within a Cooperative Clinical Trials Group? Economic Methodological Pilot Studies of the Radiation Therapy Oncology Group (RTOG) Studies 9003 and 9104, Int J Radiat Oncol Biol Phys. 45:225, 1999. Abs # 150.

    McDonald S, Scott C, Rubin P, Paris K, Demas W, Machtay M, Komaki R, Movsas B.: A Phase III Study Evaluating the Efficacy of Conventional Radiation Therapy With or Without Recombinant ƒÒ-Interferon for Patients With Locally Advanced Non-Small Cell Lung Cancer and Poor Prognostic Characteristics (RTOG #9304), Int J Radiat Oncol Biol Phys. 45:379, 1999. Abs # 2197.

    Murray K, Scott C, Zachariah B, Michalski J, Demas W, Fu K, Lukka H, Movsas B.: Importance of the Mini Mental Status Exam (MMSE) in the Treatment of Patients with Brain Metastases: A Report from the Radiation Therapy Oncology Group Protocol 9104. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, 42 261, Abstract. #2067, 1998.

    Herskovic A, Scott C, Demas W, Gaspar L, Trotti A.: Accelerated Hyperfractionation for Bronchogenic Cancer - RTOG T.I.D.  Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys. 39: 314, 1997. Abs. #2148.

    Scarantino C, Caplan R, Rotman M, Coughlin C, Demas W, Delrowe J.:  A Phase I/II Study to Evaluate the Effect of Fractionated Hemibody Irradiation in the Treatment of Osseous Bone Metastases-RTOG 88-22.  Int. J. Rad. Onc. Biol. Phys. 36:37-48, 1996.

    Demas W.:  NEOUCOM.  Radiation oncology syllabus for medical students, 1990.

    Demas W, Choi K, Aziz H, Rosenthal CJ, Shaha A, Marti JR.:  Radiation therapy single dose chemotherapy infusion for recurrent maxillary sinus carcinomas.  In Proceedings of  American Triologic Society, February 1986.

    Lawton, C., DeSilvio, M., Roach III, M., Uhl, V., Krisch, R., Seider, M., Rotman, M., Jones, C., Asbell, S., Valicenti, R., Han, S. and Thomas, C.: An Update of the Phase III Trial Comparing Whole-Pelvic (WP) to Prostate Only (PO) Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression (TAS): Updated Analysis of RTOG 94-13. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S19, Abs. #32, 2005.

    Hartsell, W., DeSilvio, M., Watkins-Bruner, D., Scarantinio, C., Ivker,R., Roach III, M., Suh, J., Seider, M., Movsas, B., Petersen, I., and Konski, A.:  Can Physicians Accurately Predict Survival Time In Patients With Metastatic Cancer? Analysis of RTOG 97-14. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S143-144, Abs. #25, 2004.

    Roach, M., DeSilvio, M., Lawton, C., Uhl, V., Machtay, M., Seider, M., Rotman, M., Jones, C., Asbell, S., Valicenti, R., Han, S., Thomas, C. and Shipley, W.: Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 94-13. J Clin Oncol, 21 (10):1904-1911, 2003.

    Roach, M., DeSilvio, M., Lawton C., Uhl, V., Machtay, M., Seider, M., Rotman, M.,Jones, C., Asbell, S., Valicenti, R., Han, S., Thomas, C. and Shipley, W.:  Neoadjuvant Hormonal Therapy (NHT) with Whole-Pelvic (WP) Radiotherapy (RT) Improves Progression-Free Survival (PFS):  RTOG (Radiation Therapy Oncology Group) 9413, a Phase III Randomized Trial.  Amer Urology Assoc (AUA), Orlando, FL, J of Urology, #500164,2002.

    Roach, M., DeSilvio, M., Lawton C., Uhl, V., Machtay, M., Seider, M., Rotman, M.,Jones, C., Asbell, S., Valicenti, R., Han, S., Thomas, C. and Shipley, W.:  Neoadjuvant Hormonal Therapy (NHT) with Whole-Pelvic (WP) Radiotherapy (RT) Improves Progression-Free Survival (PFS):  RTOG (Radiation Therapy Oncology Group) 94-13, A Phase III Randomized Trial.  Proceeding from AM Soc Clin Oncol (ASCO), Orlando, FL, J. Clin Oncol, 21 #711, “The Best of Oncology Session”, 2002.

    Roach, M., Lu, J., Lawton, C., Hsu, I.-C., Machtay, M., Seider, M., Rotman, M., Jones, C., Asbell, S., Valicenti, R., Han, S., Thomas, C. and Shipley, W.: A Phase III Trial Comparing Whole-Pelvic (WP) versus Prostate Only (PO) Radiotherapy and Neoadjuvant versus Adjuvant Total Androgen Suppression (TAS): Preliminary Analysis of Radiation Therapy Oncology Group (RTOG) 94-13. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 3, Abs. #P5, 2001.

    Murray, K., Scott, C., Greenberg, H., Emami, B., Seider, M., Vora, N., Olson, C., Whitton, A., Movsas, B. and Curran, W.: A Randomized Phase III Study of Accelerated Hyperfractionation versus Standard in Patients with Unresected Brain Metastasis: A Report of the Radiation Therapy Oncology Group (RTOG) 91-04. Int J Radiat Oncol Biol Phys, 39(3):571-574, 1997

    Seider MJ, Kim HD.  The role of purines, pyrimidines and nucleosides on cow red cell glycolysis.  Biophys J.  1997; 17:261a.

    Murray K, Scott C, Greenberg H, Emami B, Seider M, Fu K, Olson C, Lukka H, Movsas B, Curran W.  A Randomized Phase III Study of Accelerated Hyperfractionation versus Standard Fractionation in Patients with Unresected Brain Metastasis.  A report of Radiation Therapy Oncology Group (RTOG) 9104.  Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA Int J Radiat Oncol Biol Phys, 1996; 36 (1): 193,[69].

    Seider MJ, Cleary KR, Van Tassel P, Alexanian R, Schantz SP, Frias A, Fuller LM.  Plasma Cell Granuloma of the Nasal Cavity Treated by Radiation Therapy.  Cancer. 1991; 67(4).

    Seider MJ, Peters LJ, Oswald M.J.  Adjuvant transvaginal boost therapy in treatment of Stage IB and II squamous cell carcinoma of the uterine cervix.  Int J Rad Onc Biol Phys.  1987; 12 (51):168.

    Seider MJ, Rich TA, Ayala AG, Murray JA.  Results of radiation therapy for giant cell tumors of bone. Radiology. 1985; 157 (10):253.

    Seider MJ, Gruener R.  The effects of corticosteroids on rabbit muscle excitability.  Society for Neuroscience. 1985.

    Booth FW, Seider MJ, Kapp R.  Effects of various levels of contractile activity on the rate of protein synthesis in skeletal muscle.  In:  Biochemistry of Exercise IV-A [edited by J. Poortmans and G. Niset] University Press:  Baltimore, 1981:123.

    Nicholson FW, Seider MJ, Booth FW.  Insulin resistance in soleus muscle of immobilized mouse limb.  Fed Proc.  1981; 40:513.

    Tucker KR, Seider MJ, Hugman GR, Booth FW.  Protein synthesis rate in regrowing rat skeletal muscle.  Fed Proc.  1980; 39:2170.

    Seider MJ, Booth FW.  Time courses of changes in protein degradation, cathepsin B activity and weight of skeletal muscles within immobilized limbs of rats.  Biophys J. 1979; 25:243a.

    Seider MJ, Booth FW, Tucker K, Moreno J.  Effects of stretch and stimulation on protein degradation in rat diaphragms.  The Physiologist 1978; 21:107.

    Seider MJ, Astrello J, Moreno J, Booth FW, Mo B.  Morphine effects on in vitro red blood cell metabolism in normotensive and hypertensive rats.  Am Soc Anes. 1978.

    Booth FW, Seider MJ, Chen CP, McKinney RA, Tucker KR.  Influence of contractile activity upon 14c-tyrosine [14C-TYR] incorporation into skeletal muscle.  Med Sci Sport. 1978; 10:69.

    Seider MJ, Kim HD.  Stimulation of cow red cell glycolysis by a plasma factor.  Fed Proc 1977; 36:444

    Seider MJ, Kim HD.  Cow red blood cells.  I.  Effect of purines, pyrimidines and nucleosides in bovine red cell glycolysis.  Am J Physiol. 1979; 236:C255-61.

    Seider MJ, Kim HD.  Cow red blood cells.  II.  Stimulation of bovine red cell glycolysis by plasma.  Am J Physiol.  1979; 236:C262-7.

    Booth FW, Seider MJ.  Recovery of skeletal muscle after 3 months of hind-limb immobilization in rats.  J Appl Physiol.  1979; 47:435-9.

    Booth FW, Seider MJ.  Early change in skeletal muscle protein synthesis after limb immobilization of rats.  J Appl Physiol.  1979, 47:974-7.

    Seider MJ, Kapp R, Chen C-P, Booth FW.  The effects of cutting or of stretching skeletal muscle in vitro on the rates of protein synthesis and degradation.  Biochem J.  1980; 188:247-54.

    Booth FW, MacKenzie WF, Seider MJ, Gould EW.  Longevity of exercising obese hypertensive rats.  J Appl Physiol.  1980; 49:634-7.

    Tucker KR, Seider MJ, Booth FW:  Protein synthesis rates in atrophied gastrocnemius muscles after limb immobilization.  J Appl Physiol.  1981; 51:73-7.

    Seider MJ, Nicholson WF, Booth FW.  Insulin resistance for glucose metabolism in disused soleus muscle of mice.  Am J Physiol.  1982; 242:E12-8.

    Seider MJ, Rich TA, Ayala AG, Murray TA.  Giant Cell Tumors of Bone.  Treatment with Radiation Therapy.  Radiology. 1986; 161:537-40.

    Seider MJ, Peters LJ, Warton JT, Oswald MJ.  Safety of Adjunctive transvaginal Beam Therapy in the Treatment of Squamous Cell Carcinoma of the Uterine Cervix.  Int J Rad Onc Biol Phys.  1988; 14:729-35.

     

    Seider MJ, Cleary KR, van Tassel P, Alexanian R, Schantz SP, Frias A, Fuller LM.  Plasma cell granuloma of the nasal cavity treated by radiation therapy.  Cancer. 1991; 67(4):929-32.

     

    Booth FW, Seider MJ, Hugman GR.  Effects of disuse by limb immobilization on different fibre types.  In:  Plasticity of Muscle.  [edited by D. Pette] Walter de Gruyter:  Berlin, 1980: 373-83.

    Watkins-Bruner, D., Winter, K., Hartsell, W., Konski, A., Curran Jr. W., Roach III, M., Doncals, D., Movsas, B., Lee, D. and Scarantinio, C.,  Prospective Health-Related Quality of Life Valuations (Utilities) of 8 Gy in 1 Fraction vs. 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases: Preliminary Results of RTOG 97-14. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, Ga, Int J Radiat Oncol Biol Phys, [60] (1) pg. S142, Abs. #23, 2004.

    Grigsby, P., Winter, K., Komaki, R., Marcial, V., Eifel, P., Doncals, D., Stevens, R., Rotman, M. and Gaffney, D.:  Long-Term Follow-Up of RTOG 88-05:  Twice-Daily External Irradiation with Brachytherapy for Carcinoma of the Cervix.  Int J Radiat Onco Biol Phys, 54 (1):51-57, 2002.

    Grigsby, P, Winter, K, Ritsuko K, Marcial V, Eifel P, Doncals D, Stevens R, Rotman M, Gaffney D.:  Long-Term Follow-Up of RTOG 88-05:  Twice-Daily External Irradiation with Brachytherapy for Carcinoma of the Cervix, Int. J. RadiationOncology Biol. Phys., Vol. 51, No. 3, p.62, 2001.

    Doncals, D., Reisinger, S., Mohiuddin, M.:  Bladder and Bowel Complications Following Prostatectomy and High Dose Adjunctive Radiation.  Int. J. Radiat. Oncol. Biol. Phys. 27 (Supp 1), 285, 1993 (Abstract #1067)

    Call DC, Silver KH, Trochelman RD, Josephson, RA:  Hemostatic Effects of Ticlopidine and Clopidogrel Using High Shear Stress, High Flow in vitro Analysis.  Catheterization and Cardiovascular Interventions. Vol. 50, No.1, May 2000, pg. 138.

    Trochelman RD, Weiss SJ, Regiani S, Liu DY, Todd RF III:  Expression of MO3e Antigen By Cultured Human Umbilical Vein Endothelial Cells (HUVEC) Stimulated By Phorbol Myristate Acetate (PMA) and Related Pharmacological Inducers Of Protein Kinase C. Cell Immunol.  112:89-103, 1988.

    Liu DY, Lee JY, Trochelman RD, Todd RF III:  Identification of a human monocyte antigen (MO3e) associated with cellular activation and lymphokine responsiveness.  Eur. J. Immunol.  19 :721-727, 1989.

    Todd RF III, Mizukami IF, Vinjamuri SD, Trochelman RD, Hancock WW, Liu DY :  Human  Mononuclear Phagocyte Activation Antigens.  Blood Cells  16:167-182, 1990.

    Trochelman RD, Weiss SJ, Regiani S, Liu DY, Todd RF III:  Expression of MO3e antigen by human umbilical vein endothelial cells (HUVEC) stimulated by phorbol myristate acetate (PMA).  Fed Proc 46(3):758, March 1, 1987

    Koenig, Joseph M., Antoine Chahine and Oscar Ratnoff.  Inhibition of the Activation of Hageman Factor (Factor XII) by soluble Human Placental Collagens Types III, IV, and V. Journ Lab Clin Med.  1991;117:523-527

    Abramovich, DK.  The Serum CA-125 Level Is A Useful Marker of Disease Activity in Papillary Serous Carcinoma of the Endometrium.  Gynecologic Oncology ¡V Abstracts, volume 72 (number 3), 1999

    Abramovich, DK. Uroprotection with Subcutaneous MESNA in Gynecologic Cancer Patients Receiving Ifosfamide.  Gynecologic Oncology ¡V Abstracts, volume 72 (number 3), 1999.

    Hong, S., Hahn, S., Kim, J. Ryu, S., Bogart, J., Chung, C., Radiotherapy for Pharyngeal Wall Cancer:  22 Years of Experience.  Journal of KAMA; vol.4, number 1, 21-25, 1998.

    Hong, S.  1999 ASCO Program/Proceedings; Abstract no. 1571

    Dowlati A, Payne J, Robertson K, et al.  Phase I trial of combination bryostatin-1 and vincristine in B-cell malignancies.  Clin Cancer Res 7 (Suppl):  Abstract 800, 2001.

    Tagliaferro AR, Ronan AM, Payne J, Meeker LD, Tse S:  Increased lipolysis to beta-adrenergic stimulation after dehydroepiandrosterone treatment in rats.  AM J Physiol 268(6 Pt 2): R1374-80, 1995.

    Ramalingam et al, “Is surgical evaluation of the axilla necessary for locoregional control  in breast conserving therapy of early stage mammary cancer in all patients?” International Journal of Radiation Oncology *Biology*Physics, 51:3 (ASTRO 2001):  248; poster at ASTRO 2001 annual meeting.

    • Summa Health System © 2014 | All Rights Reserved | 525 East Market Street, Akron, Ohio 44304 | (888) 905-6071